RadNet Stock Analysis, Valuation (NASDAQ:RDNT)

Add to My Stocks
$11.1 $0.1 (0.91%) RDNT stock closing price Sep 22, 2017 (Closing)
Watch Robo Advisor Video of RDNT Stock Analysis
RadNet
Updated on : Sep 22, 2017
previous close
RDNT 11.1 (0%)
S&P 500 2502.2 (0%)
Closing Price On: Sep 22, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Outpatient-Home care
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q2
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
6.7%
Operating Profit
Operating Margin:
5.3%
Sector Average:
-2.3%
5 Quarter Net Profit
Net Margins
2017-Q2
%
LTM Margin
Compared to the industry
Debt/Equity Ratio
Debt:
629.1M
Debt/Equity Ratio:
 9.89
Compared to the industry
Cash Flow
Operating cash flow:
$19.3M
Net Income:
$5.3M
PROS      CONS
Operating Margins
ROIC
ROE
PS Valuation
Long Term Growth
High Debt Burden
PE Valuation
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
RDNT PS :
0.6
Industry PS :
5.3
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
4.4%
Return on Equity:
19.2%
Free Cash Flow Margin:
3%
Double Tap To Exit Full Screen
0:00
/

RadNet Stock Analysis

83 5 2

View RadNet stock analysis video. This is our analyst opinion covering the buy and sell arguments for RDNT stock.

RadNet Inc. Stock Rating 3.2/5

Our RadNet stock opinion is based on fundamentals of the company. This RadNet stock analysis is based on latest 2017 Q2 earnings. The stock price analysis takes into account the company's valuation metrics.

Should you buy RDNT stock?

  • RadNet had a healthy average operating margin of 5.3% over the last 4 quarters.
  • The lower PS ratio 0.6 for RDNT stock versus Medical-Outpatient-Home care industry average of 5.3 is a positive for the company.
  • RadNet generates a high return on invested capital of 4.4%.
  • The LTM ROE of 19.2% for RadNet is attractive.

Should you sell RDNT stock?

  • Revenue growth of 6.7% has been weak over the last 5 years.
  • With a debt/equity ratio of  9.89, RadNet is highly leveraged in comparison to Medical peers.
  • RDNT stock is trading at a PE ratio of 50.5, which is worse than the industry average multiple of 22.9.

Comments on this video and RadNet stock